Obesity and metabolic syndrome associated with systemic inflammation and the impact on the male reproductive system
Tóm tắt
Obesity and metabolic syndrome (MetS) are global epidemics, driven by an obesogenic environment. This is mediated by complex underlying pathophysiology, in which chronic inflammation is an important aetiological and mechanistic phenomenon. A shift towards a subclinical TH1–lymphocyte mediated innate and chronic inflammatory response is well defined in obesity and MetS, demonstrated in multiple systems including visceral adiposity, brain (hypothalamus), muscles, vasculature, liver, pancreas, testes, epididymis, prostate and seminal fluid. Inflammatory cytokines disrupt the hypothalamic‐pituitary‐testes axis and steroidogenesis cascades (hypogonadotropic hypogonadism), spermatogenesis (poor semen parameters, including DNA fragmentation and detrimental epigenetic modification) and results in subclinical prostatitis and prostate hyperplasia. This review aims to highlight the role of chronic inflammation in obesity and MetS, cytokines in male reproductive physiology and pathophysiology, the impact on steroidogenesis and spermatogenesis, prostate pathology and erectile dysfunction. Currently, it is recommended that clinical assessment of male infertility and reproductive dysfunction in obese and MetS patients includes inflammation assessment (highly sensitive C‐reactive protein), and appropriate advice and therapeutic options are incorporated in the management options. However, the mechanisms and therapeutic options remain poorly understood and require significant interdisciplinary research to identify potential novel therapeutic strategies.
Từ khóa
Tài liệu tham khảo
McPherson NO, 2015, Male obesity and subfertility, is it really about increased adiposity?, Asian J Androl, 17, 450, 10.4103/1008-682X.148076
Castro AM, 2017, Low‐grade inflammation and its relation to obesity and chronic degenerative diseases, Rev Med Hosp Gen (Mex), 80, 101
World Health Organisation, 2010, WHO Laboratory Manual for the Examination and Processing of Human Semen
Pinte L, 2019, Non‐alcoholic fatty pancreas disease ‐ practices for clinicians, Rom J Intern Med
Marchiani S, 2014, Metabolic syndrome‐associated sperm alterations in an experimental rabbit model: relation with metabolic profile, testis and epididymis gene expression and effect of tamoxifen treatment, Mol Cell Endocrinol, 401, 12, 10.1016/j.mce.2014.11.005
Juge‐Aubry CE, 2005, Adipose tissue: a regulator of inflammation, J Clin Endocrinol Met, 19, 547
Camera A, 2008, Metabolic syndrome: from insulin resistance to adipose tissue dysfunction, Minerva Med, 99, 307
Demirci T, 2019, The effect of chronic stress and obesity on sperm quality and testis histology in male rats; a morphometric and immunohistochemical study, Histol Histopathol, 34, 287
Winter AG, 2014, Androgen defeciency and metabolic syndrome in men, Transl Androl Urol, 3, 50
Gorbachinsky I, 2010, Metabolic syndrome and urologic diseases, Rev Urol, 12, 157
Morelli A, 2016, Hypogonadotropic hypogonadism and metabolic syndrome: insights from the high‐fat diet experimental rabbit animal model, Minerva Endocrinol, 41, 240
Abdel‐Fadeil MR, 2019, Experimental obesity and diabetes reduce male fertility: potential involvement of hypothalamic Kiss‐1, pituitary nitric oxide, serum vaspin and visfatin, Pathophysiology, S0928‐4680(18)3
Khalaf I, 2003, Efficacy and safety of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in Egypt and South Africa, Int J Impot Res, 15, 25
Madersbacher S, 2004, Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire, Eur Urol, 47, 80
Jaffar M, 2016, Does weight loss improve fertility with respect to semen parameters? Results from a large cohort study, Int J Infertil Fetal Med, 7, 94
Karayiannis D, 2016, Association between adherence to the Mediterranean diet and semen quality parameters in male partners of couples attempting fertility, Human Reprod, 32, 215